ASSAY CALIBRATION TO REFINE PREDICTION OF OATP1B1/1B3 MEDIATED DRUG-DRUG INTERACTIONS (DDI) BASED ON IN VITRO UPTAKE TRANSPORT ASSAY DATA

被引：0
|
作者：
Kovacs, Peter [1 ]
Sane, Rucha [1 ]
Cheung, Kit Wun Kathy [1 ]
Kis, Emese [1 ]
Plise, Emile [1 ]
Gaborik, Zsuzsanna [1 ]
机构：
[1] SOLVO Biotechnol, Szeged, Hungary
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P228
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] PREDICTION OF HEPATIC UPTAKE TRANSPORTER (OATP1B1) DRUG-DRUG INTERACTIONS
    Hinton, Laura K.
    Thomas, Jennifer S.
    Kenworthy, Kathryn E.
    Galetin, Aleksandra
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2007, 39 : 320 - 320
  • [2] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
  • [3] Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions
    Shitara, Yoshihisa
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) : 220 - 227
  • [4] Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
    Garrison, Dominique A.
    Talebi, Zahra
    Eisenmann, Eric D.
    Sparreboom, Alex
    Baker, Sharyn D.
    PHARMACEUTICS, 2020, 12 (09) : 1 - 18
  • [5] Cellular uptake of rose bengal is mediated by OATP1B1/1B3 transporters
    Sztandera, K.
    Gorzkiewicz, M.
    Zizzi, E. A.
    Dybczak, N.
    Poltorak, L.
    Deriu, M. A.
    Klajnert-Maculewicz, B.
    BIOELECTROCHEMISTRY, 2023, 152
  • [6] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions
    Karlgren, Maria
    Ahlin, Gustav
    Bergstrom, Christel A. S.
    Svensson, Richard
    Palm, Johan
    Artursson, Per
    PHARMACEUTICAL RESEARCH, 2012, 29 (02) : 411 - 426
  • [7] INVESTIGATING PROTEIN-MEDIATED UPTAKE DRUG-DRUG INTERACTIONS USING F-METHOTREXATE AS A SUBSTRATE FOR OATP1B1 TRANSPORTER
    Parvez, Md Masud
    Sadighi, Armin
    Keller, Steve F.
    Enoru, Julius O.
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [8] ASSAY CALIBRATION TO REFINE PREDICTION OF P-GP MEDIATED DDI BASED ON IN VITRO VESICULAR TRANSPORT ASSAY DATA
    Nerada, Zsuzsanna
    Toth, Beata
    Kis, Emese
    Zolnerciks, Joseph K.
    Gaborik, Zsuzsanna
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S93 - S94
  • [9] The Development, Characterization, and Application of an OATP1B1 Inhibition Assay in Drug Discovery
    Soars, Matthew G.
    Barton, Patrick
    Ismair, Manfred
    Jupp, Rachael
    Riley, Robert J.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1641 - 1648
  • [10] Sodium Fluorescein is a Probe Substrate for Hepatic Drug Transport Mediated by OATP1B1 and OATP1B3
    De Bruyn, Tom
    Fattah, Sarinj
    Stieger, Bruno
    Augustijns, Patrick
    Annaert, Pieter
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) : 5018 - 5030
12345